10-K/A

BIOTIME, INC 10-K A 12-31-2016

Company: Lineage Cell Therapeutics, Inc.
Filed: March 29, 2017
Period of Report: December 31, 2016
Accession Number: 0001140361-17-013668

View Document ↗ View on SEC.gov ↗